“…No significant differences in baseline median HCV RNA load were observed (5.4 log
10 IU/ml) (
Table 1)
15 . Additional clinical parameters previously reported to affect HCV replication or allograft survival, such as donor age (AM: median, 55 years; range 45–69 years; PM: median, 44 years; range, 29–64)
16 , cold-ischemia time
17 , duration and time of operation
18 were comparable in the AM or PM groups (
Table 1). In four of six patients (#3, 7, 8 and 11) in the AM group, a viral rebound toward pre-transplant levels was observed during the time of study (
Figure 2A).…”